Science & Research
Circadian Rhythm Disruptions Linked to Increased Cardiometabolic Disease Risk, American Heart Association Warns
The American Heart Association's new scientific statement reveals that disruptions to the body's internal clock significantly increase risks for obesity, Type 2 diabetes, high blood pressure and cardiovascular disease, highlighting the importance of circadian alignment for preventive health strategies.
Dr. Hos Loftus Earns 2025 Castle Connolly Top Doctor Recognition for Integrated Neurology and Psychology Care
Dr. Hos Loftus has been recognized as a 2025 Castle Connolly Top Doctor for his innovative integrated approach to neurological and psychological care at Carolinas Institute for Neurology and Psychology, highlighting the growing importance of holistic treatment models in modern healthcare.
Octane's 2025 Medical Innovation Forum to Spotlight Health Longevity Breakthroughs
Southern California's premier innovation accelerator Octane will host its 2025 Medical Innovation Forum featuring groundbreaking longevity research and wellness innovations that could transform future healthcare approaches.
Space Robotics Workers Selects Spacedock Interface for Orbital Assembly Systems
Space Robotics Workers has chosen Spacedock's intelligent interface technology to enable autonomous assembly and maintenance of orbital infrastructure, representing a significant advancement toward scalable space operations and sustainable space ecosystems.
MAX Power Mining Expands Natural Hydrogen Exploration with New Saskatchewan Target
MAX Power Mining has identified the Bracken target as its first high-priority Natural Hydrogen drilling location beyond the Genesis Trend in Saskatchewan, advancing Canada's position in the emerging natural hydrogen sector.
Nanomedicine Breakthroughs Transform Cancer Drug Delivery and Bioavailability
Recent advancements in nanomedicine technology are revolutionizing oncology treatment by improving drug delivery systems, enhancing bioavailability, and potentially transforming underperforming cancer drugs into effective therapies through platforms like Oncotelic Therapeutics' Deciparticle.
Study Reveals Chemotherapy May Damage Brain's Waste Drainage System, Explaining 'Chemo Brain' Symptoms
New research identifies chemotherapy-induced damage to the brain's waste drainage network as a potential cause of cognitive difficulties affecting up to 75% of cancer patients during and after treatment.
Aditxt Subsidiary Pearsanta Launches Clinical Study for Blood-Based Endometriosis Diagnostic
Aditxt's subsidiary Pearsanta has begun enrolling patients in a clinical study for a novel blood-based endometriosis test that could provide earlier, non-invasive detection compared to current surgical methods.
NanoViricides to Present Antiviral Pipeline Updates at PODD 2025 Conference
NanoViricides will showcase its broad-spectrum antiviral drug platform at the upcoming PODD 2025 conference, highlighting progress toward Phase II trials for its lead candidate NV-387 targeting multiple respiratory viruses and MPox.
Annovis Bio Secures $3.4 Million in Registered Direct Offering to Advance Neurodegenerative Disease Therapies
Annovis Bio has raised $3.4 million through a registered direct offering to fund development of treatments for Alzheimer's and Parkinson's diseases, providing crucial capital for advancing late-stage clinical programs targeting neurodegeneration.
KAILASA Launches 121 AI Agents to Bridge Ancient Hindu Wisdom with Modern Global Challenges
KAILASA has unveiled 121 specialized AI agents designed to make ancient Hindu scriptures and sciences accessible for addressing contemporary global issues including sustainable development, AI ethics, and scientific research.
New LED Therapy Shows Promise in Targeting Cancer Cells While Preserving Healthy Tissues
Researchers have developed a novel LED-based cancer treatment that selectively destroys cancer cells while minimizing damage to healthy tissues, potentially offering a more precise alternative to conventional therapies like chemotherapy and radiation.
MAX Power Mining to Drill Canada's First Dedicated Natural Hydrogen Well in 2025
MAX Power Mining is advancing North America's first dedicated natural hydrogen drilling program, positioning the company to potentially unlock a new clean energy source that could transform industrial power and data center operations across the continent.
Soligenix's HyBryte Shows Promise as Potential First-Line Treatment for Cutaneous T-Cell Lymphoma
Soligenix Inc. is advancing HyBryte as a potential first-line therapy for early-stage cutaneous T-cell lymphoma following promising results from clinical trials that could reshape treatment standards in the rare disease space.
D-Wave Quantum Expands European Presence With €10M Quantum Computing Initiative in Italy
D-Wave Quantum Inc. is establishing Italy as a quantum innovation hub through a €10 million contract for quantum computing access and educational seminars as part of the Q-Alliance initiative.
MAX Power Mining Receives License for Canada's First Dedicated Natural Hydrogen Well
MAX Power Mining has secured the drilling license for Canada's inaugural dedicated natural hydrogen well in Saskatchewan, marking a significant advancement in the country's clean energy transition and positioning the company as a pioneer in this emerging sector.
Chinese Surgical Innovations Transform Treatment for Previously Inoperable Liver Conditions
Advanced extracorporeal liver surgery techniques developed in China are providing new hope for patients with complex liver tumors and parasitic diseases previously considered surgically untreatable, eliminating the need for donor organs and lifelong immunosuppression.
New Novel 'Hidden in Plain Sight' Explores Intersection of Science, Mystery and Human Resilience
Author Irv Selman's new novel Hidden in Plain Sight combines science fiction with profound human themes of grief and resilience while exploring humanity's search for meaning in the cosmos.
New Melanoma Test Shows Three-Fold Improvement in Predicting Lymph Node Metastasis Risk
The Merlin CP-GEP test accurately stratifies melanoma patients by sentinel node metastasis risk, potentially reducing unnecessary surgical procedures through improved personalized care.
Xuemo's Literary Works Spark Global Dialogue on Human Spirit in AI Era at Frankfurt Book Fair
Award-winning writer Xuemo's literature emerged as a central focus at the 2025 Frankfurt Book Fair, sparking international discussions about maintaining human wisdom and compassion amid rapid technological advancement.
Updated Pediatric and Neonatal CPR Guidelines Emphasize Unique Needs of Children
The American Heart Association and American Academy of Pediatrics have released updated CPR and emergency cardiovascular care guidelines that provide specific recommendations for infants and children, addressing the approximately 27,000 pediatric cardiac arrests occurring annually in the United States.
Oncotelic Therapeutics Announces Three Abstracts on Deciparticle Everolimus Accepted for 2025 San Antonio Breast Cancer Symposium
Oncotelic Therapeutics will present three abstracts on its investigational intravenous Deciparticle everolimus at the 2025 San Antonio Breast Cancer Symposium, highlighting potential improvements over existing mTOR inhibitors for metastatic breast cancer treatment.
NanoViricides Reports NV-387 Shows Strong Antiviral Activity Against Measles in Preclinical Studies
NanoViricides' clinical lead drug candidate NV-387 demonstrated potent antiviral effects against Measles virus with significant lung protection and extended survival in animal models, potentially offering the first approved treatment for a disease that currently has no specific antiviral therapy.
Inaugural Jack Sarver Prizes Awarded to St. Louis and Dallas Researchers for Cardiovascular Disease Prevention Studies
Two scientists from Washington University and UT Southwestern received the first Jack Sarver Prizes for research addressing maternal mortality in Nigeria through aspirin prophylaxis and identifying genetic mechanisms linking liver disease to atherosclerosis.
Branded Legacy Advances FDA Pathway for Low-Cost Intranasal Naloxone Alternative
Branded Legacy's subsidiary BioLegacy Evaluative Group is preparing FDA submission materials for a proprietary intranasal naloxone spray that aims to replicate Narcan's performance while reducing costs and improving global accessibility to opioid overdose reversal medication.
Study Finds mRNA COVID Vaccine May Enhance Cancer Immunotherapy Effectiveness
New research presented at the European Society for Medical Oncology conference suggests mRNA coronavirus vaccines could potentially boost the effectiveness of cancer immunotherapy treatments.
Updated CPR Guidelines Introduce Major Changes to Choking Response and Opioid Overdose Treatment
The American Heart Association's 2025 CPR guidelines introduce significant updates including new choking protocols for all ages, expanded opioid overdose response with naloxone guidance, and a unified chain of survival system that could improve survival rates for the 350,000 annual out-of-hospital cardiac arrests in the U.S.
Local-Scale Climate Models Emerge as Critical Tool for Community Adaptation
Researchers emphasize that high-resolution local climate models are essential for translating global climate projections into actionable adaptation strategies that protect communities from extreme weather and long-term climate changes.
Themeda AI Framework Achieves 93.4% Accuracy in Predicting Australian Savanna Land Cover Changes
A new deep learning framework called Themeda demonstrates unprecedented accuracy in forecasting land cover changes across Australia's savannas, offering crucial tools for biodiversity conservation and climate adaptation.
Dual-Energy Catalysis Advances Carbon Recycling Technologies
A comprehensive review reveals how combining multiple energy sources in catalytic systems significantly improves CO2 conversion efficiency, offering new pathways for sustainable carbon recycling and greenhouse gas reduction.